Volume 4, Number 2—June 1998
Dispatch
Probable Human Infection with a Newly Described Virus in the Family Paramyxoviridae
Table
Titer |
||
---|---|---|
Serologic testa | Patient 1 | Patient 2 |
Neutralizing antibody to new agent | 128 | 512 |
Antibody to equine morbillivirus | negative | negative |
CMV IgG | positive | positive |
CMV IgM | negative | negative |
EBV-VCA IgG | positive | positive |
EBV-VCA IgM | negative | negative |
EBV-EBNA IgG | negative | positive |
Rubella IgG | positive | positive |
Rubella IgM | negative | negative |
Mycoplasma (CFT) | < 4b | 4b |
Mycoplasma IgM | negative | negative |
Adenovirus (CFT) | 8b | 8b |
Enterovirus (CFT) | 8b | 8b |
Influenza A (CFT) | 32b | 16b |
Influenza B (CFT) | 8b | <4 (negative) |
Leptospiral agglutinins | negative | negative |
Brucella antibodies | negative | negative |
Toxoplasma IgG | positive | positive |
Toxoplasma IgM | negative | negative |
Q Fever (phase 2 - CFT) | negative | negative |
Measles IgG | positive | positive |
Measles IgM | negative | negative |
Mumps IgG | positive | positive |
Mumps IgM | negative | negative |
RSV (CFT) | < 8b | anticomplementary |
Parainfluenza 1 (CFT) | 32b | < 16b |
Parainfluenza 2 (CFT) | 16b | < 16b |
Parainfluenza 3 (CFT) | < 8b | < 16b |
HBsAg | negative | negative |
anti-HBc | negative | negative |
anti-HCV | negative | positivec |
anti-HIV (Western Blot) | negative | negative |
anti-HIV (EIA) | negative | negative |
aCMV, cytomegalovirus; IgG, immunoglobulin G; EBV, Epstein-Barr virus; VCA, viral capsid antigen; EBNA, Epstein-Barr nuclear antigen; CFT, complement fixation test; RSV, respiratory syncytial virus; HBsAg, hepatitis B surface antigen; HBc, hepatitis B core; HCV, hepatitis C virus; EIA, enzyme immunoassay.
bNot significant.
cBy two screening enzyme immunoassays.
Page created: December 15, 2010
Page updated: December 15, 2010
Page reviewed: December 15, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.